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ABSTRACT 
A NOVEL ROLE FOR WNT5B IN REGULATING PROLIFERATION OF  
RADIAL GLIAL CELLS 
 
MAY 2011 
SEAN BURTON, B.A., KENT STATE UNIVERSITY 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Rolf Karlstrom 
 The wnt family of secreted glycoproteins perform diverse roles from development 
through adulthood in both vertebrate and invertebrate organisms.  These roles include the 
establishment of multiple body axes, cell polarity and migration during gastrulation, and 
prevention of tumorigenesis during adulthood. Much research has been performed to 
examine the function of the different wnt genes, however, some have received relatively 
little investigation.   
 One of the relatively unknown wnt genes is wnt5b.  My work has been 
characterizing a zebrafish with a mutation in the wnt5b gene, looking for mutations that 
caused defects in axonal and glial patterning during embryonic development.  Previously, 
wnt5b has been shown to influence planar cell polarity, and has been found to inhibit 
zebrafish fin regeneration and implicated as an inducer of type II diabetes.  However, 
little research has been performed to investigate its role in the development of the 
nervous system. 
  Here I show that wnt5b plays a direct role in regulating proliferation of radial 
glial cells in the embryonic zebrafish spinal cord.  Zebrafish with mutations in this gene 
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have a increased number of radial glial cells that are in m-phase, compared to wild type 
embryos.  I also show that wnt5b gain of function is sufficient to reduce this number well 
below wild type levels.  Here I will present findings that, when combined with what has 
been previously found about the roles of wnt5b and its link to leukemia and mammary 
tumors, suggests that wnt5b may be a candidate for further study as a route to cancer 
therapy.   
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CHAPTER 1 
BACKGROUND AND SIGNIFICANCE 
 Studies of human neuropathologies, such as nervous system tumors and 
neurodegenerative diseases, have branched out into the study central nervous system 
(CNS) development during embryogenesis.  The reason for studying CNS development is 
that either the cause or the treatment or both of these pathologies is similar to the 
processes that established the nervous system in embryo.  A relatively recent advance in 
the field of CNS research is the establishment of the zebrafish as a vertebrate model 
organism for such studies. 
Neural and glial progenitor proliferation  
The neuroepithelium and ventricular zone 
 Production of neurons and macroglia (as compared to microglia, which have 
hematopoietic origins) begin with neuroepithelial (NE) cells that line the ventricular zone 
of the inchoate neural tube, in a single, pseudostratified cell layer (Magdalena Götz & 
Wieland B Huttner, 2005).  These NE cells have a number of characteristic features; 
apical-basal polarity within the neural tube, anchored regions at the apical surface, and 
endfeet that contact the basal surface (Magdalena Götz & Wieland B Huttner, 2005; W B 
Huttner & Brand, 1997; Wodarz & Wieland B Huttner, 2003).  These cells’ nuclei also 
undergo stereotyped movements along the apical basal axis of the neural tube as they 
proceed through the cell cycle; these movements are referred to as interkinetic nuclear 
migration (Sauer, 1935; T. Takahashi, Nowakowski, & Caviness, 1993). 
2 
 
 The first wave of neurogenesis is spawned by these NE cells, while the later, 
majority of neurons and neural progenitors are produced by radial glia (Anthony, Klein, 
Fishell, & Nathaniel Heintz, 2004; Malatesta et al., 2003). 
Progenitor pool transition from neuroepithelial cells to radial glia 
 The transition from NE cells to radial glia approximately coincides with the time 
that neurogenesis begins in the CNS [cite].  This transition is marked by the expression of 
several astroglial markers such as astrocyte-specific glutamate transporter (GLAST) and 
brain lipid binding protein (BLBP) (Feng, Hatten, & N Heintz, 1994; E Hartfuss, Galli, 
Heins, & M Götz, 2001; Shibata et al., 1997), as well as glial fibrillary acidic protein 
(GFAP) (Choi, 1981; Levitt & Rakic, 1980).   
Interkinetic nuclear migration 
 Nuclei of both NE cells and radial glia undergo the process of interkinetic nuclear 
migration (INM) as they progress through the cell cycle .  INM is a cycle of stereotyped 
movements of the cells’ nucleus along the apical/basal axis of the neural tube, with each 
phase of the cell cycle corresponding to one particular location of the nucleus along the 
axis.  In the M-phase of the radial glial cell cycle, the nucleus is located at the most apical 
end of the cell.  During G1, the nucleus migrates basally, away from the ventricular 
surface.  While the cell undergoes S-phase, its nucleus is located at the basal most point 
within the ventricular zone, near the ventricular-subventricular boundary.  Finally, within 
the G2-phase, the nucleus migrates apically, to the location at which mitosis will occur.  
An illustration of this movement is seen in figure 4.   
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Figure 1: Interkinetic nuclear migration of radial glia in the neural tube/spinal cord.  
The nucleus of proliferating radial glia moves in relation to the ventricular zone 
throughout the cell cycle; being at the ventricular surface during m-phase and moving 
basally during s-phase. 
Transit amplifying progenitors 
Neural and glial progenitor migration along glial scaffolds 
Neural proliferation during adult life 
   
Cell cycle regulation 
The cell cycle 
Regulators of the cell cycle 
[Intracellular]  Promoters- Cyclins, CDKs, Cdc25s, Plk kinases... 
    Inhibitors- Wee1, Myt1, Cip/Kip members and Ink4 members... 
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[Extracellular] 
  Wnts, Notch, Shh, EGF, TGF, FGF 
The role of wnts in cell cycle regulation 
5 
 
CHAPTER 2 
MUTAGENESIS SCREEN FOR AXONAL AND GLIAL DEFECTS 
 The Hopkins lab at MIT conducted a large scale insertional mutagenesis screen in 
zebrafish with the goal of identifying mutations in genes that are necessary for embryonic 
development (Gaiano et al., 1996).  The result was the discovery of 315 genes whose 
functions are necessary for proper embryonic development in the zebrafish (Golling et 
al., 2002; Adam Amsterdam et al., 2004).  We took a subset of these mutants and 
performed a screen with the intent of identifying mutants with specific defects in CNS 
development, in particular, axonal and glial patterning (Barresi et al., 2010).  We began 
our screen with 274 of the Hopkins screen mutants and identified 115 mutants with 
axonal and/or glial defects (Barresi et al., 2010).  40 of these mutants were omitted from 
the screen because they were necrotic and may have had defects due to this necrosis 
rather than mutation specific defects (Barresi et al., 2010).  24 of the remaining mutants 
were eliminated for having very broad morphological defects; of the remaining 51 
mutants, 25 of them had reliably repeated phenotypes and these were subjected to further 
analysis (Barresi et al., 2010).  These data, along with a break down of the different 
classes of mutant phenotypes, are represented in figure 1 below.   
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Figure 2: Overview of Mutagenesis Screen Numbers.  This table shows the number of 
mutations found that fall within each category.  The 315 distinct loci were originally 
identified in the Hopkins screen.  The 25 loci with repeated phenotypes may fall into 
more than of the defect categories.  Adapted from (Barresi et al., 2010). 
  
 Three primary areas were observed for defects in CNS patterning: the forebrain, 
hindbrain and spinal cord/trunk (figure 2).  For a more detailed review of our screen see 
(Barresi et al., 2010).  Within this range of mutant phenotypes, a novel class of mutants 
was discovered.  These mutants have significant changes in the number of large Glial 
Fibrillary Acidic Protein (Gfap) positive cell bodies (figure 3); either an increase (e.g., 
arnt2, kif11, esco2) or a decrease or complete loss (e.g., ppp1r12a, pou5f1, mak16) of 
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these cell bodies (Barresi et al., 2010).  There are a number of possible reasons for the 
observed changes including gain or loss of apoptosis, changes in regulators of the cell 
cycle, or a change of cell fate for these cells’ precursors.  This change in cell numbers 
could result in several outcomes such as the loss of another cell type or disorganization of 
the CNS. 
 
Figure 3: Screening the forebrain and spinal cord 
for axonal and glial defects. Fluorescent 
Immunohistochemistry labeling axons in green 
(acetylated tubulin) and glia (Gfap) in red.  (A) A 
ventral view (anterior up) of the forebrain in a wild 
type embryo at 42hpf.  This view of the forebrain 
shows two axonal commissures bridging the midline 
(white dotted line); the anterior commissure (AC) at the 
top of the image, and the post-optic commissure (POC) 
at the bottom.  The optic chiasm is also shown here but 
is difficult to discern since it is in front of the POC in 
this view.  (B) A lateral view (anterior left) of the wild 
type spinal cord at 42hpf.  This image is taken at the 
depth of the ventricular zone.  Gfap+ cell bodies seen 
here center around the ventricle.  These cell bodies are 
only detectable when the cells are in m-phase.   
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 When our screening of these mutants was completed, I undertook further 
characterization a single screen mutant as my thesis work. I performed preliminary 
comparisons of Gfap+ cell body numbers between wild type embryos and mutant 
embryos from the radial glial class of mutants described above.  Based on preliminary 
tests which implied significance in the increase of the number of large Gfap+ cell bodies 
observed in the spinal cord, combined with my interest in secreted cell signaling 
molecule such as the Wnts, I decided to further characterize the defects of the 
hi1780b/wnt5b mutant. 
 
Figure 4: Radial glia class mutants.  All images are maximum intensity projections of 
the spinal cord, centered on the ventricular zone, anterior to the left.  Comparison of wild 
type (A) to radial glia class mutants discovered in our screen with either a decrease (B) or 
an increase (C,D) of radial glial number.  
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hi1780b is a wnt5b mutant 
 The hi1780b mutant was identified in our screen for axonal and glial defects as 
having disorganized forebrain commissure formation and an increased number of Gfap+ 
cell bodies in the spinal cord (Barresi et al., 2010).  As for gross morphology, the hi1780b 
mutant has a shorter trunk than wild type, with a tail that is noticeably curved ventrally  
and a smaller head (figure 6). 
 Since hi1780b was produced in the Hopkins screen, an insertional mutagenesis 
screen, it was easily identified as to what gene contained the viral insertion.  Since the 
sequence of the viral insert is known, PCR was performed for the region containing the 
insert, which was then sequenced and compared to the zebrafish genome.  This method 
identified the hi1780b insert as being in exon 4 of the wnt5b gene (Figure 7). 
 
 
Figure 5: Comparison of wild type and wnt5b mutant gross morphology.  In 
comparison to wild type embryos, wnt5b mutant embryos have a drastically truncated tail 
and a smaller head.  This mutant phenotype is only appears in homozygous mutants, and 
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is lethal by 5 days post fertilization, although relatively few embryos survive to 4 days.   
 
   
 
Figure 6: The viral insert in wnt5b should lead to a truncated protein.  The hi1780b 
insert from the Hopkins screen is in exon 4 of wnt5b.  It is predicted that this insert causes 
a premature stop codon and results in a severely truncated protein that lacks most of the 
Wnt domain; the domain that is responsible for wnt signaling transduction to wnt 
receptors. 
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CHAPTER 3 
RESULTS 
A loss of wnt5b function leads to an increased number of large Gfap+ cell bodies in 
the spinal cord. 
 The first step to take in the characterization of this mutant was to determine 
whether the increase in the number of large Gfap+ cell bodies in the spinal cord is 
significant.  These cells bodies could belong to a few different cell types: radial glia, 
transit amplifying progenitors (TAPs) or astrocytes, but I will discuss the determination 
of these cell’s identities later in my paper.  First, to determine whether a loss of wnt5b 
function significantly increases the number of the large Gfap+ cell bodies that we 
observed in the wnt5b mutant spinal cord, wild type and wnt5b mutant embryos were 
labeled for Gfap using fluorescent immunohistochemistry, and comparisons were made 
between groups at three time points: 24, 36 and 48hpf. The number of large Gfap+ cell 
bodies were counted within the length of 3 somites, in lateral view images of the spinal 
cord. Mutants at displayed a 2-fold increase in the number of large Gfap+ cell bodies 
(mean=19, sd=4.5, n= 24) when compared to wild type (mean=9.7, sd=2.6, n=26) (figure 
8). These numbers were compared using Welch’s T-test , t=-7.3, df=25.6, p= 1.029e-07.  
Comparisons over the time points 24, 36 and 48hpf, are shown in figure 9. 
12 
 
 
0
5
10
15
20
25
G
fa
p
+
 c
e
ll
 b
o
d
ie
s
/
3
 s
o
m
it
e
s
wild type
wnt5b mutant
wnt5b morphant
 
Figure 7:  Mutation in wnt5b leads to an increase in the number of large Gfap+ cell bodies in the 
spinal cord.  Fluorescent antibody labeling of Gfap in the spinal cord shows an increased number of 
large Gfap+ cell bodies in the wnt5b mutant in comparison to wild type.  Embryos injected with 5ng 
wnt5b MO have a similar number of cell bodies to the mutant.  Fluorescent images are lateral views of 
the spinal cord, anterior left.   
 
 I next asked whether this increase in large Gfap+ cell bodies was due to a loss of 
function of wnt5b rather than the possibility that the mutation creates a hypomorph, 
which would still generate a Wnt5b protein but with decreased function.  The wnt5b 
transcript contains 6 exons with the translation start site in exon 3 and stop codon in the 
middle of exon 6; producing a 363aa product.  The hi1780b insert is in exon 4, and 
results in a predicted truncated protein that should lack signaling function; therefore, a 
loss of function is expected, but needed to be verified.  Embryos were injected at the 1-4 
cell stage with a translation blocking morpholino oligonucleotide (MO) that should 
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provide a loss of function, which we can compare to wnt5b mutants. Comparing cell body 
numbers of the MO injected embryos (mean=16, sd=3.6, n=8) with wild type and wnt5b 
mutants revealed a similar number to the mutant (figure 8).  Welch’s T-tests between MO 
injected embryos and wild type revealed a significant difference (p=0.002), and a non-
significant difference between MOs and mutants (p=0.07).  This suggested to us that the 
mutation had a similar end result to that of the morpholino; that is, a loss of function, 
rather than a hypomorph. 
 
 
Figure 8: Average number of large Gfap+ cell bodies per 3 somites over time.  
Differences between wild type and wnt5b mutants were significant at every time point.   
 
14 
 
Injection of wnt5b RNA decreases the number of large Gfap+ cell bodies in the 
spinal cord. 
 If loss of wnt5b function is sufficient to increase the number of large Gfap+ cell 
bodies seen in the spinal cord, the next question is whether or not a wnt5b gain of 
function is sufficient to decrease this number.  To examine this, I injected wild type 
embryos with either 5 or 10pg of wnt5b RNA and performed the same assay to quantify 
large Gfap+ cell body numbers described above.  Embryos that were injected with 5pg 
wnt5b RNA had approximately half the number of large Gfap+ cell bodies (mean=5, 
sd=1, n=6) that control embryos had (mean=12, sd=2, n=6) (figure 10). A Welch’s a T-
test yielded p=0.002, a significant decrease in number in RNA injected embryos.  This 
data suggest that wnt5b plays a direct role in the regulation of the number of these cells.  
Embryos that were injected with 10pg wnt5b RNA did not survive long enough to be 
assayed. 
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Figure 9: Ectopic expression of wnt5b decreases the number of large Gfap+ cell bodies in the 
spinal cord.  Lateral views of a wild type embryo and an embryo that was injected with 5pg 
wnt5b RNA labeled for Gfap.  Ectopic expression of wnt5b decreased the number of Gfap+ cells 
by fifty percent.  
The large Gfap+ cell bodies observed in the spinal cord are radial glia. 
 To determine the identity of these cells, the first thing I did was to perform Gfap 
labeling on spinal cord cross sections from embryonic zebrafish to discern their 
morphology.  Figure 11 shows cross sections of the spinal cord from wild type and wnt5b 
mutant embryos.  These cell bodies lie near the ventricular zone with apical processes 
contacting the ventricular surface and have longer Gfap+ processes that extend toward 
the basal surface.  These morphological traits identify these cell bodies as radial glia 
(reviewed in (Kriegstein & Alvarez-Buylla, 2009).  However, radial glial cell bodies 
present in the embryonic spinal cord are only easily identified when they are in the m-
phase of mitosis, when the cell body is much larger than in the other phases of the cell 
cycle, and is positioned nearest to the ventricular surface.  
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Figure 10: Spinal cord cross sections showing radial glia.  Images show cross sections 
of wild type and wnt5b mutant spinal cords (dorsal up) at 48hpf.  Glia are labeled in 
green, axons (acetylated tubulin) in red, and nuclei (DAPI) in blue.  The large Gfap+ cell 
bodies (white boxes) in the spinal cord belong to radial glia.  They have large, dual-
nucleated somas that are next to the ventricle (medial) and long processes that extend to 
the basal surface (laterally).   
The large radial glial cell bodies observed in the spinal cord are in M-phase. 
 I observed an increase in the number of radial glial cell bodies in the mutant 
spinal cord, and their size is indicative of radial glia in the m-phase of mitosis. This 
implies that wnt5b is involved in the cell cycle of these cells.  To determine whether these 
cells are in m-phase, embryos were co-labeled for Gfap and phospho-histone H3 (PH3), a 
marker for cell nuclei in m-phase (Hendzel et al., 1997) and are shown in figure 12. 
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Radial glia in the spinal cord co-label for Gfap and PH3 in both wild type and wnt5b 
mutant embryos. Of the total number of radial glial cell bodies in the spinal cord, 86.71% 
in wild type and 88.46% in wnt5b mutants were co-labeled with PH3, a non-significant 
difference (p=0.393).  This data verifies that these radial glia are in m-phase and seem to 
be the same cells in both wild type and mutants. 
 
 
 
Figure 11: The large radial glia cell bodies in the spinal cord are in m-phase.  Double 
labeling for Gfap (green) and PH3 (red) shows co-labeling in radial glia cell bodies.  While the 
number of radial glia in the spinal cord are increased in the wnt5b mutant, the percentage of radial 
glia that are in m-phase is similar to wild type.   
The wnt5b mutant does not have a complete block in radial glial mitosis 
 Since the increased number of radial glia in the spinal cord of wnt5b are in m-
phase, I now asked the question of whether or not this mutation blocks exit from mitosis.  
This would imply a role for wnt5b in regulating radial glial proliferation.  Since these 
cells are in m-phase, I compared the wntb5 mutant with embryos treated with S-trityl-L-
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cysteine (STLC), a known inhibitor of radial glial mitosis (Brier, Lemaire, DeBonis, 
Forest, & Kozielski, 2006).  
  Radial glial cells in the CNS of embryos treated with STLC have been shown to 
be locked in mitosis, as it inhibits the separation of the mitotic spindles by blocking 
function of eg5, a motor kinesin responsible for their separation.   
 Wild type embryos were treated with 0.875mM STLC from 5 to 24hpf, and then 
fixed for immunohistochemistry.  Comparisons of MPRG cell counts in STLC treated 
embryos (mean=61, sd=14, n=7) and wnt5b mutant embryos (mean=23, sd=3, n=10) 
revealed a significantly increased number in the drug treated group (p=1.130e-06) (figure 
12).  This suggests that wn5b mutants only have a partial loss of the total proliferation of 
the spinal cord radial glia.  To determine how this may be the case, I first compared the 
location of the glial cell bodies in the wnt5b mutant with the location of the expression of 
wnt5b in the spinal cord.  To do this, I first had to establish the expression pattern of 
wnt5b during the time points I was studying.   
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Figure 12: Comparison of STLC treated embryos to wild type and wnt5b mutants.  Embryos 
were bathed in 0.875mM STLC from 5hpf to 24hpf, then fixed and processed for 
immunohistochemistry.  Embryos that had been treated with STLC have a marked increase in the 
number of radial glia in m-phase over both wild type and wnt5b mutant embryos.  This increase is 
statistically significant when compared to all other treatments.   
Embryonic expression of wnt5b 
 To determine the location of wnt5b expression, in situ hybridization was 
performed on 24, 36 and 48hpf embryos.  At 24hpf, wnt5b is expressed in the dorsal 
spinal cord, the ventral telencephalon, the dorsal diencephalon (figure 14), the tail bud, 
and the ventral midbrain and hindbrain (data not shown).  At 36 and 48hpf, expression is 
similar, 36hpf forebrain and spinal cord (figure 14), and a 48hpf spinal cord cross section 
is shown in figure 15.   
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Figure 13: Expression pattern of 
wnt5b in the spinal cord at 24, 36 and 
48hpf.  (left) Lateral views of wnt5b in 
situ hybridization in whole mount 
embryo spinal cords.  At these three 
time points wnt5b seems to be 
expressed in all but the most ventral 
regions of the spinal cord with the 
strongest expression appearing more 
dorsal. 
 
 
Figure 14: wnt5b expression in spinal 
cord cross section.  A cross section of the 
spinal cord of a 48hpf embryo.  Here, in situ 
hybridization for wnt5b shows expression to 
be dorsal and centered medially around the 
ventricular surface.  Since radial glia 
undergo mitosis at the ventricular surface 
this places wnt5b in the proper location for a 
role in the m-phase of their cell cycle. 
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Loss of wn5b Function has a Regionally Restricted Effect on Radial Glial Mitosis 
 In situ hybridization reveals that wnt5b is expressed dorsally in the spinal cord, 
with expression at its strongest nearer the ventricle.  To determine if wnt5b is directly 
regulating cell cycle progression of radial glia in proximity to its region of expression, 
Gfap labeled lateral spinal cord images were divided into 5 rows of equal height along 
the dorsal ventral axis (1=most dorsal, 5=most ventral) and the number of MPRG in each 
of those rows was recorded (figure 16).  Whereas wild type embryos have a roughly even 
distribution of MPRG along the dorsal/ventral axis, wnt5b mutant embryos have an 
increased number of these cells in the 2
nd
 and 3
rd
 rows; a region that correlates with the 
portion of the spinal cord where wnt5b is expressed (mean data shown in figure 17).   
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Figure 15: Distribution of MPRG cell bodies over the dorsal/ventral axis.  (A) 
Diagram of dorsal/ventral axis division into fifths for the purpose of describing radial glia 
cell body location, 1=most dorsal, 5=most ventral.  (B) Dorsal/Ventral cell body counts 
were done on lateral views of the spinal cord from maximum intensity projections of ~40 
m thick Z-stack Apotome images.  Gfap and PH3 were co-labeled to best determine the 
location of the glial cell bodies.  (Chart) Dorsal/Ventral distributions of cell bodies in 
both wild type and STLC treated embryos showed no difference along the axis.  
However, wnt5b mutant embryos showed a significant increase in the number of cells in 
the second row, which corresponds to the location of the strongest wnt5b expression.  
Row 3, with the next strongest expression, showed a very nearly significant increase as 
well (Tukey test, p=0.06). 
 Both wild type and STLC treated embryos show an even distribution of MPRG 
cells along the dorsal/ventral axis.  However, the wnt5b mutant has a significantly 
increased number of MPRG cell bodies in row 2, the row that corresponds most to the 
expression of wnt5b along the dorsal/ventral axis.  Interestingly, the only row that 
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showed a significant difference between wild type and mutants was row 2 (p=0.0049), 
although row 3, the row with the strongest wnt5b expression after row 2, was close 
(p=0.06), and with an increase in sample size, may also show a difference. 
Row wild type wnt5b mutant STLC treated 
1 2 4 13 
2 3 11 17 
3 3 6 15 
4 2 4 15 
5 2 1 13 
 
Figure 16: Average number of cell bodies by row, along  
the dorsal/ventral axis.  1=most dorsal, 5=most ventral. 
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Discussion 
A novel role for wnt5b as a regulator of Radial Glial Proliferation 
 The results described above reveal a role for wnt5b in regulating proliferation of 
spinal cord radial glia during CNS development.  The finding that a loss of function 
mutation in wnt5b results in an increased number of radial glial cell bodies in the spinal 
compared to wild type embryos suggests that wnt5b negatively regulates proliferation of 
these radial glia.  This increase in the number of radial glial cell bodies is seen across 
ages, at 24, 36, and 48 hours post fertilization.  Unfortunately, wnt5b is a gene that is 
required for embryonic development, so that embryos with the hi1780b insertion in 
wnt5b do not survive through the embryonic stage, days 0-5.  In fact, these homozygote 
mutant embryos rarely live as long as 72 hours post fertilization, making it difficult to 
collect data from ages older than 48 hours in any significant amount.  Conversely, I have 
shown that, over expression of wnt5b RNA leads to a decrease in the number of large 
radial glial cell bodies.  This suggests that wnt5b plays a direct role in regulating the 
proliferation of these radial glia.   
 The findings that a decrease in wnt5b function increases the number of radial glia 
and that an increase in wnt5b function decreases the number of radial glia is in direct 
agreement with other findings (Y. Lee et al., 2009; Stoick-Cooper et al., 2007), in which 
they found the same outcomes in regards to blastemal cells of the fin in fin regeneration 
studies.  Thus, it should not be surprising then to find similar results in regards to 
proliferation of radial glia.  However, the question still remains as to how wnt5b regulates 
the proliferation of radial glial. 
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Proposed model for the regulation of proliferation in radial glia by wnt5b 
 While the work presented above reveals a novel role for wnt5b in regulation of 
radial glial proliferation, there still remains many questions as to how wnt5b regulates 
this process.  I propose the following model to describe the way in which wnt5b regulates 
the proliferation of radial glia (figure 18).   
 Radial glia in the neural tube/spinal cord are originally derived from neural 
epithelial cells.  These radial glia will begin to proliferate, generating both neural and 
glial precursors.  When the radial glia are in the m-phase, they reach one of the cell cycle 
check points in which proliferating cells must meet certain requirements, such as a lack 
of DNA damage, in order to continue the cell cycle.  Failure to pass checkpoints in either 
of the g-phases of the cell cycle results in p53 activation and apoptosis (reviewed in 
(Chiarugi, Magnelli, Cinelli, & Basi, 1994).  I propose that wnt5b function is necessary to 
pass through a similar checkpoint for the radial glia in m-phase.  Without this wnt5b 
signal, the m-phase checkpoint requirements are not met, and the cell undergoes a 
process called mitotic catastrophe (Portugal, Mansilla, & Bataller, 2010).  Mitotic 
catastrophe is a relatively uncharacterized means of cell death, as compared to apoptosis 
and necrosis.  While molecular markers for mitotic catastrophe are not yet identified,  
cells undergoing this process have a multi-nucleated cell body before death.  The radial 
glia that were found to be increased in number in my study have a similar morphology to 
the cells described as undergoing mitotic catastrophe.  This could be the reason why I did 
not observe an accumulation of radial glia over time, rather a similar increase at all time 
points.  This would also account for the similarity in radial glial cell number in the  wn5b 
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mutants and embryos co-injected with wnt5b and p53 morpholino, as mitotic catastrophe 
is not dependent on p53 activation (Portugal et al., 2010).  
  
Figure 17: Model for wnt5b regulation of proliferation of radial glia.  (Left) With functioning 
wnt5b radial glia will pass through m-phase and continue the cell cycle.  (Right) Without wnt5b, 
mitotic radial glia will arrest in m-phase and undergo mitotic catastrophe. 
 Wnt5b may be an important target for cancer treatment 
 The work I have presented here suggests a novel role of wnt5b as a direct 
regulator of proliferation of the radial glial , which are neural stem cells, in the embryonic 
zebrafish spinal cord.  As current thought in cancer research now regards cancer cells as 
mutated stem cells, this may imply a role for wnt5b in preventing tumorigenesis.  This 
link between wnt5b and cancer has already been shown in other research directed at 
understanding cancer stem cells (see (Kuorelahti, Rulli, Huhtaniemi, & Poutanen, 2007; 
D. Lu et al., 2004; Mangioni et al., 2005; H. O. Sercan, Pehlivan, Simsek, Ates, & Z. 
Sercan, 2007).  As defects in wnt5b can lead to the inappropriate increase in neural stem 
cell number, this could imply an importance for further research of wnt5b as a target for 
cancer therapy 
27 
 
Materials and Methods 
Fish Lines and Ethics Approval 
 Zebrafish lines used in all the described experiments were maintained at the 
University of Massachusetts, Amherst.  Embryos were raised in Embryo Rearing 
Medium (ERM) and staged according to (C. B. Kimmel, Ballard, S. R. Kimmel, 
Ullmann, & Schilling, 1995)).  Embryos were dechorionated with 10mg/ml Pronase 
(Sigma), fixed at the desired stage in 4% Paraformaldehyde (Ted Pella), and stored in 
100% MeOH at -20C.  Mutant hi1780b embryos were identified by gross morphology. 
The Institutional Animal Care and Use Committee of the University of Massachusetts 
Amherst approved the housing and maintenance of animals and all experimental 
protocols. 
Immunohistochemistry and In Situ Hybridization 
 Immunohistochemistry was performed as previously described (Barresi, Hutson, 
Chien, & Rolf O Karlstrom, 2005), with minor modifications.  Briefly, embryos aged 48 
hours post fertilization (hpf) were incubated in 100% acetone at -20C for 10 minutes.  
Phosphate Buffered Saline (PBS) with 0.3% Triton X (PBS-Tx), was used for rehydration 
and blocking solution, as well as all washes with the exception of six 10-minute washes 
in PBS-0.1%Tw (Tween) performed after incubation in secondary antibody.  Embryos 
were digested in 10µg/ml Proteinase K (Pro K) for varying durations depending upon 
age, 18hpf-0 min, 24hpf-5 min, 36hpf-10 min, and 48hpf-25 min.  Blocking solution 
consisted of PBS with the addition of 0.3% Tx, 2% BSA, 2% DMSO and 5% NGS.   All 
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antibodies were diluted in blocking solution; primary antibodies were incubated 
overnight at 4C, secondary antibodies were incubated for 2 h at room temperature.   
 The anti-goldfish-Gfap antibody (generous donation from Sam Nona, University 
of Manchester, UK) was used at a dilution of 1:400 to label glial cell bodies and 
processes (Marcus & Easter, 1995).  Radial glia were also labeled using Zrf-1 antibody 
(monoclonal IgG1, ZIRC) at a dilution of 1:10 (Trevarrow, Marks, & C. B. Kimmel, 
1990).  Acetylated tubulin antibody (monoclonal IgG2b, Sigma) was used at a 
concentration of 1:800 to label axons (Wilson, Ross, Parrett, & Easter, 1990).  Phospho-
Histone H3 antibody (monoclonal IgG1, 6G3 Cell Signaling) was used to label cells in 
the M-phase of the cell cycle (Kaitna, Pasierbek, Jantsch, Loidl, & Glotzer, 2002) at a 
dilution of 1:100.  A BrdU antibody (monoclonal IgG1, G3G4 Hybridoma Bank) was 
used at a dilution of 1:10 to label cells that have passed through the S-phase of mitosis.  
PCNA antibody (polyclonal, Santa Cruz) was used to label cells that are in late G1 to S-
phase of the cell cycle, at a dilution of 1:50. 
 Probes used for in situ hybridization were digoxigenin-labeled anti-sense mRNA 
probes, synthesized using SP6 or T7 Dig RNA Labeling Kits (Roche).  Primers used to 
synthesize axin2 and vim probes are as follows; axin2 forward primer sequence 
GAGAGCGACCGACAAACCAAG, reverse primer sequence 
CATTGGCAGAACTGTGCAGTC, and vim forward primer sequence 
GCAGATCCAGATGCAGGAGC, reverse primer sequence 
CGTCTCTGGTCTCGATGGTC. Additional probes used in this study include wnt5b, 
sfrp5 (Tendeng & Houart, 2006), ascl1a (Pogoda et al., 2006), prl and pomc (Herzog et 
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al., 2003). In situ hybridizations were performed as previously described (R O Karlstrom, 
Talbot, & Schier, 1999). 
BrdU Treatments 
 BrdU stock solution (50mM) was thawed at 37C for 30 minutes, added to ERM 
at a dilution of 1:5.  Embryos were incubated in BrdU solution for 1, 2, 3, and 4 h, and 
then transferred to fresh ERM to wash out BrdU and then to a second dish of ERM to 
grow to the desired age.  Embryos are fixed overnight at 4C.  BrdU antibody labeling 
protocol follows the above immunohistochemistry protocol with one exception.  After 
Pro K has been washed out 3x5 minutes in PTx, all embryos are rinsed 2x in 2N HCl, 
incubated in 2N HCl for 1 hour incubation; followed by 2x rinse and 3x10 minutes wash 
in PTx.   
Cloning wnt5b  
 The wnt5b coding sequence (CDS) was cut from its original vector (unknown 
vector, with only ~1000bp 5’ and 3’ of the wnt5b CDS known) in a digest reaction using 
EcoRV and SpeI for 2 h at 37C, followed by 20 min incubation at 65C to inactivate the 
enzymes.  To blunt the ends of the wnt5b fragment, 0.3µl of dNTPs and 0.5µl Klenow 
were added to the reaction and incubated at room temperature for 15 min, followed by 20 
min incubation at 75C with 1µl 0.5M EDTA, to inactivate the Klenow.  The wnt5b CDS 
were then ligated into a pCS2+ vector to gain a poly(A) tail.  The pCS2+ was cut in the 
same digest reaction described above, using StuI.  The reaction was then treated with 
0.3µl calf intestinal alkaline phosphatase (CIP) for 1 hour at 37C to prevent self-ligation 
of the vector. 
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 Both the wnt5b insert and the pCS2+ vector were run out on a 1.5% agarose gel 
for 1 h at 85 V, in separate wells.  The gel was visualized using a Gel Doc 2000 (Bio 
Rad) and the two bands excised for purification using ZR-96 Zymoclean™ Gel DNA 
Recovery Kit (Zymo Research).  10µl ligation reactions (0.5µl NEB ligase, 1µl NEB 
ligase buffer, 2µl insert, 1µl vector and 5.5µl Sigma water) were incubated overnight at 
16C.   
 Ligated product was then transformed in E. coli. A 4µl reaction volume was 
combined with 100µl E. coli cells, and placed on ice for 30 min. Cells were then heat 
shocked at 42C for 1 min. and then placed on ice for 2 min.  Finally, 500µl SOC 
medium was added to the cells, which were incubated at 37C for 1.5 h.  Cells were then 
plated on carbenicillin plates and left to incubate at 37C overnight.  Eight samples were 
taken from a plate and prepared using a QIAprep Spin Miniprep Kit (Qiagen).  To test 
directionality of the insertion, digest reactions were performed using BamHI, and 
checked by gel electrophoresis.   
RNA and Morpholino Injections 
 The wnt5b/pCS2+ plasmid was linearized using APAI, and wnt5b RNA was 
transcribed using SP6 polymerase (Message Machine-SP6 kit, Ambion).  RNA was 
diluted in 1x Danio solution, as described (Devine et al., 2009).  Embryos were injected 
with 5pg (Jopling & den Hertog, 2005) or 10pg of wnt5b RNA at the 1-4 cell stages.  
Injected embryos were raised at 28C until the desired age and fixed in 4% PFA 
overnight at 4C. 
 Pilot morpholino injection experiments were performed using a sample of the 
wnt5b morpholino (Jopling & den Hertog, 2005), generously provided by Jeroen den 
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Hertog.  Experimental data presented here used the wnt5b translation blocking MO (Open 
Biosystems) with sequence: CGCCTCCTCAGATGGAAGTTCTTGG, targets a site 32 
bases 5’ of the start site.  MO injection followed the same process as RNA injection 
described above.  MO was injected at doses of 1, 2, 3, 4, 5 and 6ng.  The wnt5b 
morpholino was either injected alone, or co-injected with a p53 morpholino at 4ng; no 
difference in gross morphology nor radial glia cell number was detected between the two 
treatments. 
Cryosections 
 Embryos used for obtaining spinal cord cross sections were not treated with 
MeOH after fixation, instead they were stored in PBS-Tw at 4C. Embryos were 
embedded in 1.5% agar, 5% sucrose blocks, which were then equilibrated in 30% sucrose 
overnight at 4C.  Coronal sections of zebrafish embryos were made using a Leica CM 
1950 cryostat.  Sections were cut 40µm thick to capture cell bodies in the spinal cord, and 
mounted on slides.  These sections were antibody labeled using the above protocol with 
some minor modifications.  Briefly, 0.1% PTw was used in place of PTx in all cases.  
Washes and rinses were performed in slide jars (Scienceware); while incubations in 
antibodies were performed in slide boxes (Evergreen) with slide covers applied after 
antibody solution.  These covers were dissociated from the slides during washes and 
discarded.  After washing out the secondary antibodies, ProLong® Gold antifade reagent 
with DAPI (Invitrogen) was applied, and a slide cover was again added to the slides.   
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APPENDIX 
EXTRA MATERIAL  
 
Wnt signaling  
 The wnt family of secreted signaling molecules consists of a large number of 
different growth factor proteins, with approximately 19 members of the family in humans 
and 24 members in zebrafish (Rao & Kuhl, 2010; Sprague et al., 2006).  They are 
responsible for a variety of functions both during embryonic development and adulthood 
including proliferation, cellular polarity, cell fate determination and differentiation, and 
cell death (Jeffrey R Miller, 2002; Logan & Roel Nusse, 2004; Rao & Kuhl, 2010).  
Before Wnt proteins are secreted from the cells within which they are generated, they 
undergo post-translational modification in the form of glycosolation, a modification that 
seems to be necessary for functional wnt signaling (Gavin, J. A. McMahon, & A. P. 
McMahon, 1990; Logan & Roel Nusse, 2004).  In Drosophila, the Wnt homolog 
Wingless is glycosolated by the transmembrane protein Porcupine, without which wnts 
are not secreted, but remain in the endoplasmic reticulum (Cadigan & R Nusse, 1996; T 
Kadowaki, Wilder, Klingensmith, Zachary, & Perrimon, 1996; Logan & Roel Nusse, 
2004).  Zebrafish have a porcupine homolog, zgc:55392, which is predicted to play a role 
similar to porcupine in wnt signaling (Strausberg et al., 2002), buy is relatively 
uncharacterized.  Once the wnt molecules have been successfully glycosylated, they are 
secreted from the cell of origin and are transported between cells by interacting with 
heparin-sulfated forms of proteoglycans (G H Baeg, X Lin, Khare, Baumgartner, & 
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Perrimon, 2001; X Lin, Buff, Perrimon, & Michelson, 1999; X Lin & Perrimon, 1999; 
Tsuda et al., 1999). 
 Once the secreted wnt molecule reaches the receiving cell, it binds to a member of 
the Frizzled (Fzd) family of transmembrane receptors (Bhanot et al., 1996).  The Fzd 
receptors have seven transmembrane domains and a long N-terminal region that contains 
a cysteine-rich domain; it is this domain to which the wnt molecule binds (Bhanot et al., 
1996; Dann et al., 2001; J. C. Hsieh, Rattner, Smallwood, & Nathans, 1999).  The wnts 
also bind to a number of co-receptors, including the low density lipoprotein receptor-
related protein (LRP) family of single transmembrane domain co-receptors, without 
which, Fzd receptors are unable to transduce the wnt signal (Pinson, Brennan, Monkley, 
Avery, & Skarnes, 2000; Tamai et al., 2000).  The extracellular portion of the wnt 
signaling pathway is conserved between wnt family members.  However, when the signal 
reaches the receiving cell, one of multiple signaling cascades may be activated.   
 Within the receiving cell, wnt signaling is divided into three categories: the 
Wnt/-catenin, or canonical, pathway, the Wnt/JNK pathway, and the Wnt-Calcium 
pathway (figure 5), the latter two were formerly grouped together under the umbrella 
category of non-canonical (Elston & Clifton-Bligh, 2010).  Which pathway is initiated at 
this point is dependent upon several factors, for example, which wnt member is involved 
and which receptor it binds to (Kawano & Kypta, 2003).  
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Figure A1: Intracellular components of the Wnt signaling pathways.  Wnt signaling 
can take one of three primary paths once it reaches the receiving signal.  The canonical 
pathway is illustrated (left) in both the inactivated (-catenin degradation) and activated 
(-catenin stabilization) forms.  The non-canonical pathways (the JNK and Ca pathways) 
are illustrated on the right.  Much less is known about these two pathways in comparison 
to the canonical pathway. 
 
 Canonical wnt signaling begins with the activated Fzd receptor interacting with 
the scaffolding protein, Disheveled (Dvl) (Wallingford & Habas, 2005; Wong et al., 
2003).  Dvl then interacts with Axin, causing Axin to bind to the cytoplasmic domain of  
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LRP, and this process disrupts a complex consisting of Axin, Adenomatous Polyposis 
Coli (APC), glycogen synthase kinase-3 (GSK3) and casein kinase 1 (CK1) (Amit et 
al., 2002; Hart, de los Santos, Albert, Rubinfeld, & Polakis, 1998; S. Kishida et al., 1998; 
Chunming Liu et al., 2002; Yanagawa et al., 2002; Yost et al., 1996).  This Axin complex 
normally binds -catenin and phosphorylates it so that it is ubiquitinated by E3 ubiquitin 
ligase and then degraded by the proteosome (Aberle, Bauer, Stappert, Kispert, & Kemler, 
1997; Latres, Chiaur, & Pagano, 1999; C Liu et al., 1999).  When Dvl disrupts this 
complex, it allows -catenin to avoid phosphorylation and subsequent degradation and 
instead accumulate in the nucleus, where it binds as a co-activator to T cell 
factor/lymphoid enhancer factor (TCF/LEF) to activate canonical wnt target genes 
(Behrens et al., 1996; Cox et al., 1999; J R Miller & R T Moon, 1997; Molenaar et al., 
1996; Tolwinski & Wieschaus, 2004; van de Wetering et al., 1997).  This canonical wnt 
signaling pathway is thus also referred to as the -catenin dependent pathway, as 
compared to the non-canonical/-catenin independent pathways. 
 Compared to the well studied canonical pathway, the wnt/JNK and wnt/Calcium 
pathways are less well characterized.  These pathways are both activated by certain wnts, 
such as wnt5a and wnt11, that have been described as non-canonical wnts (Elston & 
Clifton-Bligh, 2010). Despite these inherent difficulties, it has been shown that wnt5b, 
which signals primarily through the JNK pathway, is capable of inhibiting the wnt/-
catenin pathway (Kanazawa et al., 2005; Masuko Katoh & Masaru Katoh, 2007) 
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The role of wnts in CNS development 
 Extensive research has been done on many members of the Wnt signaling family 
in various model organisms.  Much of this research has focused on the roles that various 
Wnts play in development.  In mouse, for example, studies on mutants with loss of 
function mutations in several Wnt genes have produced defects in CNS development 
including loss of midbrain and cerebellum development (Ikeya, S. M. Lee, Johnson, A. P. 
McMahon, & Takada, 1997; Mastick et al., 1996; A. P. McMahon & Bradley, 1990; A. 
P. McMahon, Gavin, Parr, Bradley, & J. A. McMahon, 1992; Thomas, Musci, Neumann, 
& Capecchi, 1991), decrease in the number of dorsal neural tube derivatives (Ikeya et al., 
1997), loss of the hippocampus (S. M. Lee, Tole, Grove, & A. P. McMahon, 2000), and a 
reduction of the number of proliferating cells (Yamaguchi, Bradley, A. P. McMahon, & S 
Jones, 1999).  
 Furthermore, it has also been shown in humans that wnt signaling plays an 
important role in tumorigenesis (J R Miller, Hocking, Brown, & R T Moon, 1999; 
Polakis, 2000).  More specifically, mutations in components of the canonical wnt 
signaling pathway, such as APC, Axin and -catenin, can lead to an increased 
accumulation of -catenin in the nucleus, which has been highly correlated with a 
number of types of human cancers (Polakis, 2000; Satoh et al., 2000).  This implies an 
importance for researching the functions of wnts as a route to discovering and improving 
methods of treating cancer.   
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Human Diseases and wnt5b 
 WNT5B has been identified as playing a role in several human diseases.  Changes 
in WNT5B expression have been found in association with both osteoarthritis and Type II 
diabetes mellitus (Hopwood, Tsykin, Findlay, & Fazzalari, 2007; Kanazawa et al., 2005, 
2004).  Of even greater interest to my work is the close connection found between 
changes in WNT5B expression and cancer.   
 Wnt5b is over expressed in several types of cancers including mammary tumors, 
chronic lymphocytic leukemia, and uterine leiomyoma (Kuorelahti et al., 2007; D. Lu et 
al., 2004; Mangioni et al., 2005).  Moreover, it has also been found to be over expressed 
in chronic myeloid leukemia cells that are undergoing drug-induced apoptosis (H. O. 
Sercan et al., 2007).  In all, these findings suggest an importance in better characterizing 
the functions of wnt5b, with implications for formulating treatments for several types of 
cancer.    
 
The spinal cord radial glia mutants that we identified in our screen have changes in the 
number of large Gfap+ cell bodies observed in the spinal cord.  Previous work 
(Alexandre, Reugels, Barker, Blanc, & Clarke, 2010) has shown that the large size and 
ventricular location of these cell bodies suggests that they are radial glia in the M-phase 
of the cell cycle.  This is in part due to a phenomenon that these radial glia undergo, 
referred to as interkinetic nuclear migration, which is the movement of the radial glial 
nucleus over the course of the cell cycle (Taverna & Wieland B Huttner, 2010). During 
M-phase the radial glial nucleus is near the ventricular surface and during S-phase it is 
located more basally within ventricular zone (Alexandre et al., 2010; Taverna & Wieland 
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B Huttner, 2010) (figure 4).  However, because of the location of Gfap protein in relation 
to the cell body, the radial glial cell body is only able to be visualized with Gfap labeling 
during M-phase, when Gfap accumulates near in the cell body (März et al., 2010).  If it is 
the case that the wnt5b mutation affects the number of radial glia in M-phase, it may be 
the case that wnt5b plays a role in the cell cycle of these radial glia.   
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